124 related articles for article (PubMed ID: 38091775)
1. PREDICT-GTN 2: Two-factor streamlined models match FIGO performance in gestational trophoblastic neoplasia.
Parker VL; Winter MC; Tidy JA; Palmer JE; Sarwar N; Singh K; Aguiar X; Hancock BW; Pacey AA; Seckl MJ; Harrison RF
Gynecol Oncol; 2024 Jan; 180():152-159. PubMed ID: 38091775
[TBL] [Abstract][Full Text] [Related]
2. PREDICT-GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?
Parker VL; Winter MC; Tidy JA; Hancock BW; Palmer JE; Sarwar N; Kaur B; McDonald K; Aguiar X; Singh K; Unsworth N; Jabbar I; Pacey AA; Harrison RF; Seckl MJ
Int J Cancer; 2023 Mar; 152(5):986-997. PubMed ID: 36346113
[TBL] [Abstract][Full Text] [Related]
3. Evaluation and simplification of risk factors in FIGO 2000 scoring system for gestational trophoblastic neoplasia: a 19-year retrospective analysis.
Weng Y; Liu Y; Benjoed C; Wu X; Tang S; Li X; Xie X; Lu W
J Zhejiang Univ Sci B; 2022 Mar; 23(3):218-229. PubMed ID: 35261217
[TBL] [Abstract][Full Text] [Related]
4. Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study.
Braga A; Paiva G; Ghorani E; Freitas F; Velarde LGC; Kaur B; Unsworth N; Lozano-Kuehne J; Dos Santos Esteves APV; Rezende Filho J; Amim J; Aguiar X; Sarwar N; Elias KM; Horowitz NS; Berkowitz RS; Seckl MJ
Lancet Oncol; 2021 Aug; 22(8):1188-1198. PubMed ID: 34181884
[TBL] [Abstract][Full Text] [Related]
5. Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified? A new retrospective analysis from a nationwide dataset.
Eysbouts YK; Ottevanger PB; Massuger LFAG; IntHout J; Short D; Harvey R; Kaur B; Sebire NJ; Sarwar N; Sweep FCGJ; Seckl MJ
Ann Oncol; 2017 Aug; 28(8):1856-1861. PubMed ID: 28459944
[TBL] [Abstract][Full Text] [Related]
6. Doppler-based predictive model for methotrexate resistance in low-risk gestational trophoblastic neoplasia with myometrial invasion: prospective study of 147 patients.
Qin J; Zhang S; Poon L; Pan Z; Luo J; Yu N; Wang L; Wu X; Cheng X; Xie X; Lu Y; Lu W
Ultrasound Obstet Gynecol; 2021 May; 57(5):829-839. PubMed ID: 32385928
[TBL] [Abstract][Full Text] [Related]
7. Human Chorionic Gonadotropin (hCG) Regression Curve for Predicting Response to EMA/CO (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide and Vincristine) Regimen in Gestational Trophoblastic Neoplasia.
Rattanaburi A; Boonyapipat S; Supasinth Y
Asian Pac J Cancer Prev; 2015; 16(12):5037-41. PubMed ID: 26163637
[TBL] [Abstract][Full Text] [Related]
8. Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13.
Bolze PA; Riedl C; Massardier J; Lotz JP; You B; Schott AM; Hajri T; Golfier F
Am J Obstet Gynecol; 2016 Mar; 214(3):390.e1-8. PubMed ID: 26433171
[TBL] [Abstract][Full Text] [Related]
9. Results with Floxuridine, Actinomycin D, Etoposide, and Vincristine in Gestational Trophoblastic Neoplasias with International Federation of Gynecology and Obstetrics Scores ≥5.
Li Y; Kong Y; Wan X; Feng F; Ren T; Zhao J; Yang J; Xiang Y
Oncologist; 2021 Dec; 26(12):e2209-e2216. PubMed ID: 34396643
[TBL] [Abstract][Full Text] [Related]
10. [The influence of lung metastasis on prognosis of previously untreated gestational trophoblastic neoplasia patients].
Lin JJ; Jiang F; Xiang Y; Wan XR; Feng FZ; Ren T; Yang JJ; Zhao J
Zhonghua Zhong Liu Za Zhi; 2022 Oct; 44(10):1139-1145. PubMed ID: 36319461
[No Abstract] [Full Text] [Related]
11. Clinical characteristics and prognosis of ultra high-risk gestational trophoblastic neoplasia patients: A retrospective cohort study.
Kong Y; Yang J; Jiang F; Zhao J; Ren T; Li J; Wang X; Feng F; Wan X; Xiang Y
Gynecol Oncol; 2017 Jul; 146(1):81-86. PubMed ID: 28461032
[TBL] [Abstract][Full Text] [Related]
12. GestaTIonal TrophoblAstic NeoplasIa Ultrasound assessMent: TITANIUM study.
Verri D; Pasciuto T; Epstein E; Fruscio R; Mascilini F; Moro F; Scambia G; Valentin L; Testa AC
Int J Gynecol Cancer; 2019 Sep; 29(7):1216-1220. PubMed ID: 31248946
[TBL] [Abstract][Full Text] [Related]
13. Treatment of extremely high risk and resistant gestational trophoblastic neoplasia patients in King Chulalongkorn Memorial Hospital.
Oranratanaphan S; Lertkhachonsuk R
Asian Pac J Cancer Prev; 2014; 15(2):925-8. PubMed ID: 24568520
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for methotrexate resistance in low-risk gestational trophoblastic neoplasia patients (FIGO score 0-4).
Jin T; Zhou Z; Lin M; Yuan S; Xue Y; Yin T; Xu R; Chen B; Zhang J; Sun J; Li X; Hu Y; Chen L; Wang H
Am J Cancer Res; 2024; 14(3):1353-1362. PubMed ID: 38590416
[TBL] [Abstract][Full Text] [Related]
15. Linear regression of postevacuation serum human chorionic gonadotropin concentrations predicts postmolar gestational trophoblastic neoplasia.
Lybol C; Sweep FC; Ottevanger PB; Massuger LF; Thomas CM
Int J Gynecol Cancer; 2013 Jul; 23(6):1150-6. PubMed ID: 23714707
[TBL] [Abstract][Full Text] [Related]
16. The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid.
Taylor F; Grew T; Everard J; Ellis L; Winter MC; Tidy J; Hancock BW; Coleman RE
Eur J Cancer; 2013 Oct; 49(15):3184-90. PubMed ID: 23870384
[TBL] [Abstract][Full Text] [Related]
17. Combining serum peptide signatures with International Federation of Gynecology and Obstetrics (FIGO) risk score to predict the outcomes of patients with gestational trophoblastic neoplasia (GTN) after first-line chemotherapy.
Wang F; Wang ZR; Ding XS; Yang H; Guo Y; Su H; Wan XR; Wang LJ; Jiang XY; Xu YH; Chen F; Cui W; Feng FZ
Front Oncol; 2022; 12():982806. PubMed ID: 36338720
[TBL] [Abstract][Full Text] [Related]
18. Evaluation and influence of lung metastasis on patient outcome in gestational trophoblastic neoplasia: A 10-year study at a single institution.
Yu H; Li J; Zhu T; Xue X; Lu X
Eur J Obstet Gynecol Reprod Biol; 2020 Aug; 251():162-166. PubMed ID: 32505789
[TBL] [Abstract][Full Text] [Related]
19. [Application of chest CT scan in gestational trophoblastic neoplasia with lung metastasis].
Cheng Y; Ma FH; Wang XR; Le XN; Zhang GF; Lu X
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):384-389. PubMed ID: 29961280
[No Abstract] [Full Text] [Related]
20. [Preliminary study of PD-1 inhibitor in the treatment of drug-resistant recurrent gestational trophoblastic neoplasia].
Cheng HY; Yang JJ; Zhao J; Ren T; Feng FZ; Wan XR; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2020 Jun; 55(6):390-394. PubMed ID: 32842245
[No Abstract] [Full Text] [Related]
[Next] [New Search]